Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Scientific Reports|February 16, 2024
Life course plasma metabolomic signatures of genetic liability to Alzheimer's diseaseHannah Compton, Madeleine L Smith, Caroline Bull, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 25, 2022
Linear and Nonlinear Associations Between Vitamin D and Grip Strength: A Mendelian Randomization Study in UK BiobankSnehal M Pinto Pereira, Victoria Garfield, Thomas Norris, et al.
Annals of Neurology|March 10, 2023
β2-Adrenoreceptor Agonists, Montelukast, and Parkinson Disease RiskBojing Liu, Per Svenningsson, Jonas F Ludvigsson, et al.
The Journal of Clinical Endocrinology and Metabolism|February 25, 2021
Investigating the Relationship Between IGF-I, IGF-II, and IGFBP-3 Concentrations and Later-Life Cognition and Brain VolumeAntoine Salzmann, Sarah-Naomi James, Dylan M Williams, et al.
Plos Medicine|August 23, 2017
Association of pre-pregnancy body mass index with offspring metabolic profile: Analyses of 3 European prospective birth cohortsDiana L Santos Ferreira, Dylan M Williams, Antti J Kangas, et al.
Aging Cell|August 25, 2021
A genome-wide association study of the frailty index highlights brain pathways in ageingJanice L Atkins, Juulia Jylhävä, Nancy L Pedersen, et al.
Nature Aging|April 20, 2026
Repurposing drugs for the prevention of vascular dementia using evidence from drug target Mendelian randomizationVictoria Taylor-Bateman, Phazha Bothongo, Venexia Walker, et al.
Annals of Human Genetics|May 22, 2012
Molecular and population analysis of natural selection on the human haptoglobin duplicationSantiago Rodriguez, Dylan M Williams, Philip A I Guthrie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2024
Common infections and neuroimaging markers of dementia in three UK cohort studiesRebecca E Green, Carole H Sudre, Charlotte Warren-Gash, et al.
BMJ Open Diabetes Research & Care|January 25, 2024
Incident dementia risk among patients with type 2 diabetes receiving metformin versus alternative oral glucose-lowering therapy: an observational cohort study using UK primary healthcare recordsWilliam Doran, Louis Tunnicliffe, Rutendo Muzambi, et al.
Pageof 6